A Visionary Breakthrough: Dr. Sanjay Kamat performs first ever ocular implant iDose in Lake Havasu City, AZ
Barnet Dulaney Perkins is leading the way in glaucoma treatment, performing a revolutionary ocular treatment for the full range of glaucoma disease to significantly decrease the dependence of daily eye drops.
Lake Havasu City, AZ — August 13, 2025 — Barnet Dulaney Perkins is thrilled to announce Dr. Sanjay Kamat and his team successfully performed the first-ever iDose TR implantation in Lake Havasu City, AZ. iDose TR is a new, groundbreaking FDA approved treatment that is designed to provide long duration, continuous drug therapy directly inside the eye, helping patients take better control over the elevated eye pressure associated with open-angle glaucoma or ocular hypertension. This innovative device, developed by Glaukos, delivers sustained-release medication directly into the eye, reducing or even eliminating the need for daily drops.
More than 3 million people in the United States are affected by Glaucoma, an eye disease caused by increased pressure in the eye and it can also cause damage to the optic nerve which carries visual information from the eyes to the brain. If left untreated, glaucoma can cause permanent damage to the eye, which means vision loss cannot be reversed. Prescription eye drops are the most common treatment for glaucoma, but they can be difficult to administer correctly and can cause uncomfortable or irritating side effects for most patients. High rates of non-compliance and non-adherence to prescription medications contribute to disease progression.
“With iDose TR, this innovative device delivers sustained-release medication directly into the eye, which reduces, and can even eliminate the need for the patient to have to self-administer eye drops multiple times a day, which may cause unpleasant side effects” said Dr. Sanjay Kamat. By delivering an effective therapy directly inside of the eye, iDose TR is an alternative to prescription eye drops and a hands-free way to keep eye pressure under control. “It is great to be able to offer the latest technology available in glaucoma management. Achieving great pressure control, having less side effects, being less dependent on daily eyedrops, and preventing permanent vision loss are great improvements in quality of life for our patients”, says Dr. Kamat.
Developed by Glaukos, iDose TR reduces high or elevated pressure within the eye by automatically releasing the same type of medication used for decades in the most commonly prescribed eye drops. During a clinical study, 8 out of 10 patients did not need prescription eye drops 12 months after administration of iDose TR. iDose TR may be particularly beneficial for patients who have difficulty adhering to a daily medication regimen or whose condition is uncontrolled on topical glaucoma medications. “Barnet Dulaney Perkins is dedicated to providing our patients with the most advanced treatment options available, iDose gives physicians and patients a solution for the huge problem of non-compliance when using drops”, says Dr. Kamat.
Advantages of iDose® TR
- Sustained Medication Release: Delivers consistent levels of medication, reducing IOP fluctuations.
- Improved Compliance: Eliminates the need for daily eye drops, addressing adherence challenges.
- Minimally Invasive Procedure: Implanted during a quick outpatient procedure with minimal recovery time.
- Reduced Side Effects: By delivering medication directly into the eye, it minimizes common side effects associated with topical treatments.
- Long-Term Efficacy: Clinical studies have shown that approximately 80% of patients remained free from additional glaucoma medications for at least 12 months post-implantation.
To learn more about innovative glaucoma treatments available at Barnet Dulaney Perkins Eye Center, visit www.goodeyes.com or call 602-955-1000 to schedule a comprehensive medical eye exam.
About Barnet Dulaney Perkins Eye Center
Barnet Dulaney Perkins Eye Center, an affiliate of American Vision Partners, has been providing state-of-the-art medical and surgical eye care in Arizona for over 35 years. With a commitment to advanced technology and compassionate care, its team of experienced eye specialists helps patients protect, improve and preserve their sight for life.
For media inquiries, please contact:
Chris La Fleur | chris.lafleur@americanvisionpartners.com|